Platform·Energy/Renewable Energy·June 15, 2026
Prime Radiant Partners acquires Cellares
The platform investment centers on a company specializing in automated cell therapy manufacturing, with transaction terms undisclosed in the announcement.
Takeaways
- Prime Radiant Partners is acquiring Cellares.
- Disclosed scale includes $50M.
BuyerPrime Radiant Partners
TargetCellares
SponsorPrime Radiant Partners
TypePlatform
IndustryEnergy
Sub-sectorRenewable Energy
Prime Radiant Partners invested $50 million in Cellares, a company specializing in automated cell therapy manufacturing.
The investment gives Prime Radiant exposure to a biomanufacturing platform focused on scaling cell therapy production.
Terms beyond the disclosed investment amount were not provided.
Daily PE deal brief
Get tomorrow morning's tape in your inbox.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up before the workday starts.